Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis

Roberta Magliozzi1,2, Owain William Howell3,4, Pascal Durrenberger3

  • 1Department of Brain Sciences, Department of Medicine, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, Burlington Danes Building, Du Cane Road, London, W12 0NN, UK. rmagliozzi73@gmail.com.

Abstract

Insights

Meningeal inflammation in multiple sclerosis (MS) alters tumor necrosis factor (TNF) signaling in the brain, promoting grey matter damage and neurodegeneration. This highlights a key pathway driving MS pathology.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Cortical pathology in secondary progressive multiple sclerosis (MS) is linked to meningeal inflammation and grey matter lesions.
  • Meningeal inflammation involves lymphoid-like structures and significant neuronal/glial loss.

Purpose of the Study:

  • To investigate molecular changes in the motor cortex due to meningeal inflammation in MS.
  • To understand the consequences of pro-inflammatory molecules from the meninges on grey matter.

Main Methods:

  • Gene expression profiling of motor cortex from 20 MS brains and 10 controls.
  • Analysis of brains with and without substantial meningeal inflammation.
  • RT-PCR confirmation of gene expression changes.

Main Results:

  • MS brains showed significant pathological cell changes, exacerbated by meningeal inflammation.
  • Genes in tumor necrosis factor (TNF) signaling pathways were deregulated in MS.
  • Increased meningeal inflammation shifted TNF signaling towards pro-apoptotic pathways in grey matter.

Conclusions:

  • Meningeal inflammation in MS generates an inflammatory environment affecting the subarachnoid space.
  • This inflammatory milieu drives demyelination and neurodegeneration in the underlying grey matter.
  • Altered TNF signaling balance is a key mechanism mediating grey matter pathology in MS.